PortalPublikationenCritical assessment of tools to predict clinically insignifi...

Critical assessment of tools to predict clinically insignificant prostate cancer at radical prostatectomy in contemporary men.

Standard

Critical assessment of tools to predict clinically insignificant prostate cancer at radical prostatectomy in contemporary men. / Chun, Felix; Haese, Alexander; Ahyai, Sascha; Walz, Jochen; Nazareno, Suardi; Capitanio, Umberto; Graefen, Markus; Erbersdobler, Andreas; Huland, Hartwig; Karakiewicz, Pierre I.

in: CANCER-AM CANCER SOC, Jahrgang 113, Nr. 4, 4, 2008, S. 701-709.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Chun, F, Haese, A, Ahyai, S, Walz, J, Nazareno, S, Capitanio, U, Graefen, M, Erbersdobler, A, Huland, H & Karakiewicz, PI 2008, 'Critical assessment of tools to predict clinically insignificant prostate cancer at radical prostatectomy in contemporary men.', CANCER-AM CANCER SOC, Jg. 113, Nr. 4, 4, S. 701-709. <http://www.ncbi.nlm.nih.gov/pubmed/18553365?dopt=Citation>

APA

Chun, F., Haese, A., Ahyai, S., Walz, J., Nazareno, S., Capitanio, U., Graefen, M., Erbersdobler, A., Huland, H., & Karakiewicz, P. I. (2008). Critical assessment of tools to predict clinically insignificant prostate cancer at radical prostatectomy in contemporary men. CANCER-AM CANCER SOC, 113(4), 701-709. [4]. http://www.ncbi.nlm.nih.gov/pubmed/18553365?dopt=Citation

Vancouver

Chun F, Haese A, Ahyai S, Walz J, Nazareno S, Capitanio U et al. Critical assessment of tools to predict clinically insignificant prostate cancer at radical prostatectomy in contemporary men. CANCER-AM CANCER SOC. 2008;113(4):701-709. 4.

Bibtex

@article{a8582e2e97f74c3fa65406527a93d97d,
title = "Critical assessment of tools to predict clinically insignificant prostate cancer at radical prostatectomy in contemporary men.",
abstract = "BACKGROUND: Overtreatment of prostate cancer (PCa) is a concern, especially in patients who might qualify for the diagnosis of insignificant prostate cancer (IPCa). The ability to identify IPCa prior to definitive therapy was tested. METHODS: In a cohort of 1132 men a nomogram was developed to predict the probability of IPCa. Predictors consisted of prostate-specific antigen (PSA), clinical stage, biopsy Gleason sum, core cancer length and percentage of positive biopsy cores (percent positive cores). IPCa was defined as organ-confined PCa (OC) with tumor volume (TV)",
author = "Felix Chun and Alexander Haese and Sascha Ahyai and Jochen Walz and Suardi Nazareno and Umberto Capitanio and Markus Graefen and Andreas Erbersdobler and Hartwig Huland and Karakiewicz, {Pierre I}",
year = "2008",
language = "Deutsch",
volume = "113",
pages = "701--709",
journal = "CANCER-AM CANCER SOC",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "4",

}

RIS

TY - JOUR

T1 - Critical assessment of tools to predict clinically insignificant prostate cancer at radical prostatectomy in contemporary men.

AU - Chun, Felix

AU - Haese, Alexander

AU - Ahyai, Sascha

AU - Walz, Jochen

AU - Nazareno, Suardi

AU - Capitanio, Umberto

AU - Graefen, Markus

AU - Erbersdobler, Andreas

AU - Huland, Hartwig

AU - Karakiewicz, Pierre I

PY - 2008

Y1 - 2008

N2 - BACKGROUND: Overtreatment of prostate cancer (PCa) is a concern, especially in patients who might qualify for the diagnosis of insignificant prostate cancer (IPCa). The ability to identify IPCa prior to definitive therapy was tested. METHODS: In a cohort of 1132 men a nomogram was developed to predict the probability of IPCa. Predictors consisted of prostate-specific antigen (PSA), clinical stage, biopsy Gleason sum, core cancer length and percentage of positive biopsy cores (percent positive cores). IPCa was defined as organ-confined PCa (OC) with tumor volume (TV)

AB - BACKGROUND: Overtreatment of prostate cancer (PCa) is a concern, especially in patients who might qualify for the diagnosis of insignificant prostate cancer (IPCa). The ability to identify IPCa prior to definitive therapy was tested. METHODS: In a cohort of 1132 men a nomogram was developed to predict the probability of IPCa. Predictors consisted of prostate-specific antigen (PSA), clinical stage, biopsy Gleason sum, core cancer length and percentage of positive biopsy cores (percent positive cores). IPCa was defined as organ-confined PCa (OC) with tumor volume (TV)

M3 - SCORING: Zeitschriftenaufsatz

VL - 113

SP - 701

EP - 709

JO - CANCER-AM CANCER SOC

JF - CANCER-AM CANCER SOC

SN - 0008-543X

IS - 4

M1 - 4

ER -